Deep learning tool identifies bacteria in micrographs
Omnipose, a deep learning software, is helping to solve the challenge of identifying varied and miniscule bacteria in microscopy images. It has gone beyond this initial goal to identify several other types of tiny...
New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells – Mirage...
NYU Langone Health / NYU Grossman School of MedicineTargeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly evolve to thwart their action. A second drug class, immunotherapies, harnesses the...
Novel Target Discovered for Potentially Treating and Preventing Osteoarthritis
Scientists at UF Scripps Biomedical have described a specific protein that manages activities within chondrocytes, a critical cell type that maintains healthy cartilage in joints. As people age and stress their joints, their chondrocytes...
Patients with clinical depression “stopped seeking treatment” during the COVID waves
In the first study of its kind, German researchers have shown that the COVID pandemic saw a huge drop in the number of patients being admitted to hospital for clinical depression. Independently of these...
Robotic intracellular electrochemical sensing for adherent cells
A research team from Southern University of Science and Technology developed an automated intracellular sensing system, which provides a high-efficiency approach to reveal cellular intrinsic characteristics and heterogeneity for better investigation of disease progression...
Scientists call for de-politicisation of agricultural biotechnology – Kenya Broadcasting Corporation
Scientists in agricultural biotechnology arena have called for a de-politicisation of the Genetically Modified Organisms (GMO) debate if Kenya is to reap the benefits of the technology and enhance food security. They urged those...
Multi-center study sheds light on understudied breast cancer type
PITTSBURGH, Oct. 14, 2022 — A multi-center analysis of patients with invasive lobular carcinoma, or ILC — the second most common histological subtype of invasive breast cancer in the U.S. — showed that, despite...
Meet Challenges in Expressing Next-Gen Immunotherapies and Other Advanced Biologics
Broadcast Date: October 28, 2022Time: 8:00 am PT, 11:00 am ET, 17:00 CET
REGISTER NOW
As the biologics market continues to grow and the industry focuses on identifying novel targets and mechanisms to generate more effective therapeutics,...
Matchpoint Therapeutics Launches to Develop Covalent Medicines
Although covalent drugs have been used for more than a century, the emergence of new tools has helped spur recent advances in the field. Indeed, covalent medicine experienced a resurgence roughly 15 years ago.
Now,...
Hypoxia-Fetal Hemoglobin Link May Lead to Novel Sickle Cell Therapies
Scientists at St. Jude Children’s Research Hospital and other colleagues say they have shown how a protein responsible for adapting to low oxygen conditions (hypoxia), causes increased expression of fetal hemoglobin (HbF) in adults....
